Loading organizations...
§ Venture Capital · Seoul, South Korea
Biotech company developing conditionally active protein therapeutics for oncology and other diseases, targeting immune cells.
Bonum Capital operates as an investment group, deploying capital across a diverse range of asset classes. The firm specializes in private equity, international public markets, venture capital, and real estate, providing comprehensive investment management services. Its approach involves active participation in portfolio companies, aiming to foster growth and support recovery strategies.
Murat Aliev founded Bonum Capital in 2013, establishing the firm with a vision to build a versatile investment vehicle. His insight centered on creating a robust platform capable of navigating and capitalizing on opportunities across various financial markets and sectors, building a significant presence in the investment landscape.
The firm's clients include investors seeking strategic asset management and companies requiring capital for expansion or restructuring. Bonum Capital is dedicated to continuously developing its investment portfolio and leveraging its expertise to identify and realize value within its holdings, consistently working towards a forward-looking and expansive financial strategy.
Boneum Investment has 1 tracked investment across 1 company. The latest tracked deal is $20.2M Series B in AITRICS INC. in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 26, 2024 | AITRICS INC. | $20.2M Series B | BNH Investment, BSK Investment, Premier Partners | DS Investment & Securities, HAN River Partners, HB Investment, Shinyoung Securities, Ulmus Investment |